Patents matching “antagonist”

US 7354581

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

US 7354894

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Apr 8, 2008 · Expires Apr 3, 2028

US 7354582

Use of VEGF antagonists for the treatment of malignant gliomas

REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

US 7348324

Cyclic amine compounds as CCR5 antagonists

Takeda Pharmaceutical Company Limited · Granted Mar 25, 2008 · Expires Mar 20, 2028

US 7345060

Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Theravance, Inc. · Granted Mar 18, 2008 · Expires Mar 13, 2028

US 7329669

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Feb 12, 2008 · Expires Feb 7, 2028

US 7312231

Quinuclidine carbamate derivatives and their use as M3 antagonists

Almirall Prodesfarma S.A. · Granted Dec 25, 2007 · Expires Dec 20, 2027

US 7300940

Integrin α-v β-3 antagonists for use in imaging and therapy

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 27, 2007 · Expires Nov 22, 2027

US 7294344

Sustained-release preparation for AII antagonist, production and use thereof

Takeda Pharmaceutical Company Limited · Granted Nov 13, 2007 · Expires Nov 8, 2027

US 7288657

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Oct 30, 2007 · Expires Oct 25, 2027

US 7273710

Method for screening MCH receptor antagonist/agonist

Takeda Pharmaceutical Company Limited · Granted Sep 25, 2007 · Expires Sep 20, 2027

US 7265133

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Sep 4, 2007 · Expires Aug 30, 2027

US 7262205

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Aug 28, 2007 · Expires Aug 23, 2027

US 7253171

Urea derivatives as integrin α4 antagonists

Laboratories Almirall, S.A. · Granted Aug 7, 2007 · Expires Aug 2, 2027

US 7252929

Methods for identifying alpha PDGFR agonists and antagonists

United State of America, As Represented by the Secretary, Dept. of Health and Human Services · Granted Aug 7, 2007 · Expires Aug 2, 2027

US 7250414

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Jul 31, 2007 · Expires Jul 26, 2027

US 7229995

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Jun 12, 2007 · Expires Jun 7, 2027

US 7229986

Melanin-concentrating hormone antagonist

Takeda Pharmaceutical Company Limited · Granted Jun 12, 2007 · Expires Jun 7, 2027

US 7211252

Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists

The Board of Regents of the University of Texas System · Granted May 1, 2007 · Expires Apr 26, 2027

US 7208515

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Apr 24, 2007 · Expires Apr 19, 2027

US 7208579

IL4 receptor antagonists for horse, dog and cat

The Regents of the University of California · Granted Apr 24, 2007 · Expires Apr 19, 2027

US 7208501

Quinuclidine carbamate derivatives and their use as M3 antagonists

Almirall Prodesfarma S.A. · Granted Apr 24, 2007 · Expires Apr 19, 2027

US 7205411

Aminopyridine derivatives as mGluR5 antagonists

Addex Pharmaceuticals S.A. · Granted Apr 17, 2007 · Expires Apr 12, 2027

US 7179815

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Feb 20, 2007 · Expires Feb 15, 2027